We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

178 hedge funds and large institutions have $1.39B invested in NxStage Medical Inc. in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 62 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more funds holding in top 10

Funds holding in top 10: 411 (+7)

48% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 25

24% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 50

6% more funds holding

Funds holding: 168178 (+10)

14% less capital invested

Capital invested by funds: $1.61B → $1.39B (-$219M)

73% less call options, than puts

Call options by funds: $1.92M | Put options by funds: $7.12M

Holders
178
Holders Change
+10
Holders Change %
+5.95%
% of All Funds
4.04%
Holding in Top 10
11
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+175%
% of All Funds
0.25%
New
37
Increased
62
Reduced
50
Closed
25
Calls
$1.92M
Puts
$7.12M
Net Calls
-$5.2M
Net Calls Change
-$30.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Envestnet Asset Management
201
Envestnet Asset Management
Illinois
-$237 -9 -43%

NXTM Hedge Fund Activity: Q4 2017 in Review

178 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2017, worth a combined $1.39B — down 14% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new NXTM positions and 25 closed out — a net gain of 12 holders — while 62 added to existing stakes and 50 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $22.8M. The largest seller was Deerfield Management, exiting entirely with an estimated $43.6M sold.

  • 178 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2017, up from 168 in Q3 2017.
  • Funds reported $1.39B of NxStage Medical Inc. stock for Q4 2017, down 14% quarter-over-quarter.
  • 37 funds opened new NxStage Medical Inc. positions in Q4 2017 and 25 closed out, a net change of +12 holders.
  • The largest NxStage Medical Inc. buyer in Q4 2017 was TIG Advisors LLC, an estimated $22.8M added.
  • The largest NxStage Medical Inc. seller in Q4 2017 was Deerfield Management, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.